首页 > 最新文献

Infection and Chemotherapy最新文献

英文 中文
Cytomegalovirus Retinitis in a Hematopoietic Stem Cell Transplant Recipient During Maribavir Pre-emptive Therapy.
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2025-01-22 DOI: 10.3947/ic.2024.0131
Hyeon Mu Jang, Han-Seung Park, Heungsup Sung, Sung-Han Kim

We report a case of cytomegalovirus retinitis in a hematopoietic stem cell transplant recipient during valganciclovir pre-emptive therapy followed by maribavir. Analysis of UL97 mutation revealed a C480F substitution associated with high maribavir resistance and low ganciclovir resistance.

{"title":"Cytomegalovirus Retinitis in a Hematopoietic Stem Cell Transplant Recipient During Maribavir Pre-emptive Therapy.","authors":"Hyeon Mu Jang, Han-Seung Park, Heungsup Sung, Sung-Han Kim","doi":"10.3947/ic.2024.0131","DOIUrl":"https://doi.org/10.3947/ic.2024.0131","url":null,"abstract":"<p><p>We report a case of cytomegalovirus retinitis in a hematopoietic stem cell transplant recipient during valganciclovir pre-emptive therapy followed by maribavir. Analysis of UL97 mutation revealed a C480F substitution associated with high maribavir resistance and low ganciclovir resistance.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143366685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV Immunocompromised Patient in Korea: A Review and Algorithm Proposed by Expert Consensus Group.
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2025-01-20 DOI: 10.3947/ic.2024.0148
Raeseok Lee, Kyungmin Huh, Chang Kyung Kang, Yong Chan Kim, Jung Ho Kim, Hyungjin Kim, Jeong Su Park, Ji Young Park, Heungsup Sung, Jongtak Jung, Chung-Jong Kim, Kyoung-Ho Song

Pneumocystis jirovecii pneumonia (PJP) is a life-threatening infection commonly observed in immunocompromised patients, necessitating prompt diagnosis and treatment. This review evaluates the diagnostic performance of various tests used for PJP diagnosis through a comprehensive literature review. Additionally, we propose a diagnostic algorithm tailored to non-human immunodeficiency virus immunocompromised patients, considering the specific characteristics of current medical resources in Korea.

{"title":"Diagnosis of <i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV Immunocompromised Patient in Korea: A Review and Algorithm Proposed by Expert Consensus Group.","authors":"Raeseok Lee, Kyungmin Huh, Chang Kyung Kang, Yong Chan Kim, Jung Ho Kim, Hyungjin Kim, Jeong Su Park, Ji Young Park, Heungsup Sung, Jongtak Jung, Chung-Jong Kim, Kyoung-Ho Song","doi":"10.3947/ic.2024.0148","DOIUrl":"https://doi.org/10.3947/ic.2024.0148","url":null,"abstract":"<p><p><i>Pneumocystis jirovecii</i> pneumonia (PJP) is a life-threatening infection commonly observed in immunocompromised patients, necessitating prompt diagnosis and treatment. This review evaluates the diagnostic performance of various tests used for PJP diagnosis through a comprehensive literature review. Additionally, we propose a diagnostic algorithm tailored to non-human immunodeficiency virus immunocompromised patients, considering the specific characteristics of current medical resources in Korea.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143366693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Linezolid-Resistant Coagulase-Negative Staphylococci in a Tertiary Hospital: Molecular Epidemiology, Clinical Characteristics, and Outcomes.
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2025-01-17 DOI: 10.3947/ic.2024.0111
Svetlana Rachina, Vladimir Gostev, Vyacheslav Pleshkov, Olga Karpova, Svetlana Topolyanskaya, Georgy Melkonyan, Marina Gladkikh, Khadizhat Zainalabidova, Polina Chulkova, Sergey Sidorenko

We report linezolid-resistant coagulase-negative Staphylococcus (LRCoNS) bacteremia at a tertiary hospital. LRCoNS with linezolid and tedizolid minimum inhibitory concentrations of >32 and 4-32 mg/L, respectively, were isolated from blood cultures of seven elderly patients who died post-bacteremia detection. Linezolid was administered to six of these patients at the time of LRCoNS isolation. Linezolid-resistant S. epidermidis ST5 isolates (LRSE) harboring mecA were isolated in seven of the nine episodes. Linezolid resistance is associated with mutations in the 23S rRNA, L3 and L4 ribosomal proteins, indigenous methyltransferases RlmN, and the presence of the cfr gene. All LRSE-ST5 genomes formed a single phylogenetic cluster.

{"title":"Linezolid-Resistant Coagulase-Negative Staphylococci in a Tertiary Hospital: Molecular Epidemiology, Clinical Characteristics, and Outcomes.","authors":"Svetlana Rachina, Vladimir Gostev, Vyacheslav Pleshkov, Olga Karpova, Svetlana Topolyanskaya, Georgy Melkonyan, Marina Gladkikh, Khadizhat Zainalabidova, Polina Chulkova, Sergey Sidorenko","doi":"10.3947/ic.2024.0111","DOIUrl":"https://doi.org/10.3947/ic.2024.0111","url":null,"abstract":"<p><p>We report linezolid-resistant coagulase-negative <i>Staphylococcus</i> (LRCoNS) bacteremia at a tertiary hospital. LRCoNS with linezolid and tedizolid minimum inhibitory concentrations of >32 and 4-32 mg/L, respectively, were isolated from blood cultures of seven elderly patients who died post-bacteremia detection. Linezolid was administered to six of these patients at the time of LRCoNS isolation. Linezolid-resistant <i>S. epidermidis</i> ST5 isolates (LRSE) harboring <i>mec</i>A were isolated in seven of the nine episodes. Linezolid resistance is associated with mutations in the 23S rRNA, L3 and L4 ribosomal proteins, indigenous methyltransferases RlmN, and the presence of the <i>cfr</i> gene. All LRSE-ST5 genomes formed a single phylogenetic cluster.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143366697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phylogenetic Analysis of Escherichia coli according to Phenotypic Resistance in Urinary Tract Infections in Children, Lima, Peru.
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2025-01-14 DOI: 10.3947/ic.2024.0101
Adriana Belén Prieto Farfan, Yesica Llimpe Mitma de Barrón, Melina Magali Mayorca Yarihuamán, Fortunato Martín Príncipe Laines, María Bertha Paredes Pérez, Jaeson Santos Calla Choque, Heli Jaime Barrón Pastor

Background: Phylogenetic studies are essential for understanding the virulence and resistance factors of bacteria, especially in evaluating their distribution within specific populations for effective infection control. Urinary tract infections (UTIs) caused by Escherichia coli are highly prevalent and pose significant health challenges from childhood to adulthood. The rising incidence of multidrug-resistant (MDR) strains highlights the urgent need for research aimed at developing preventive measures and epidemiological control strategies. This study aimed to analyze phylogenetically uropathogenic E. coli strains and their resistance phenotypes in children.

Materials and methods: A retrospective analysis was conducted on 111 urine culture samples collected from June 2023 to February 2024 at the Pediatric Emergency Hospital (PEH) in Lima, Peru. The phylogroups of E. coli were identified using Clermont's protocol based on polymerase chain reaction.

Results: UTIs were predominantly observed in females (85.6%) and infants under two years old (42.3%). The most frequent uropathogenic E. coli phylogroups were B2 (30.6%), D (29.7%), and A (25.2%). These phylogroups showed significant correlation with MDR and the production of extended spectrum beta-lactamases (ESBL).

Conclusion: At PEH, UTIs in children are primarily caused by uropathogenic E. coli from the B2 and D phylogroups, which demonstrate high virulence and resistance factors. The correlation between these phylogroups, MDR, and ESBL production, along with the increasing infection rates associated with phylogroup A, suggests a potential for horizontal gene transfer. This underscores the urgent need for vigilant control measures.

{"title":"Phylogenetic Analysis of <i>Escherichia coli</i> according to Phenotypic Resistance in Urinary Tract Infections in Children, Lima, Peru.","authors":"Adriana Belén Prieto Farfan, Yesica Llimpe Mitma de Barrón, Melina Magali Mayorca Yarihuamán, Fortunato Martín Príncipe Laines, María Bertha Paredes Pérez, Jaeson Santos Calla Choque, Heli Jaime Barrón Pastor","doi":"10.3947/ic.2024.0101","DOIUrl":"https://doi.org/10.3947/ic.2024.0101","url":null,"abstract":"<p><strong>Background: </strong>Phylogenetic studies are essential for understanding the virulence and resistance factors of bacteria, especially in evaluating their distribution within specific populations for effective infection control. Urinary tract infections (UTIs) caused by <i>Escherichia coli</i> are highly prevalent and pose significant health challenges from childhood to adulthood. The rising incidence of multidrug-resistant (MDR) strains highlights the urgent need for research aimed at developing preventive measures and epidemiological control strategies. This study aimed to analyze phylogenetically uropathogenic <i>E. coli</i> strains and their resistance phenotypes in children.</p><p><strong>Materials and methods: </strong>A retrospective analysis was conducted on 111 urine culture samples collected from June 2023 to February 2024 at the Pediatric Emergency Hospital (PEH) in Lima, Peru. The phylogroups of <i>E. coli</i> were identified using Clermont's protocol based on polymerase chain reaction.</p><p><strong>Results: </strong>UTIs were predominantly observed in females (85.6%) and infants under two years old (42.3%). The most frequent uropathogenic <i>E. coli</i> phylogroups were B2 (30.6%), D (29.7%), and A (25.2%). These phylogroups showed significant correlation with MDR and the production of extended spectrum beta-lactamases (ESBL).</p><p><strong>Conclusion: </strong>At PEH, UTIs in children are primarily caused by uropathogenic <i>E. coli</i> from the B2 and D phylogroups, which demonstrate high virulence and resistance factors. The correlation between these phylogroups, MDR, and ESBL production, along with the increasing infection rates associated with phylogroup A, suggests a potential for horizontal gene transfer. This underscores the urgent need for vigilant control measures.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143366701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reinfection of SARS-CoV-2 Variants in Immunocompromised Patients with Prolonged or Relapsed Viral Shedding.
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2025-01-13 DOI: 10.3947/ic.2024.0098
Ji Yeun Kim, Euijin Chang, Hyeon Mu Jang, Jun Ho Cha, Ju Yeon Son, Choi Young Jang, Jeong-Sun Yang, Joo-Yeon Lee, Sung-Han Kim

Background: Immunocompromised patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection often have prolonged viral shedding, and some are clinically suspected of reinfection with different SARS-CoV-2 variants. However, data on this issue are limited. This study investigated the SARS-CoV-2 variants in serially collected respiratory samples from immunocompromised patients with prolonged viral shedding for over 12 weeks or relapsed viral shedding after at least 2 weeks of viral clearance.

Materials and methods: From February 2022 to September 2023, we prospectively enrolled immunocompromised patients with coronavirus disease 2019 who had hematologic malignancies or had undergone transplantation and were admitted to a tertiary hospital. Weekly saliva or nasopharyngeal swabs were collected from enrolled patients for at least 12 weeks after diagnosis. Genomic RNA polymerase chain reaction (PCR) was performed on samples, and those testing positive underwent viral culture to isolate the live virus. Spike gene full sequencing via Sanger sequencing and real-time reverse transcription-PCR for detecting mutation genes were conducted to identify SARS-CoV-2 variants.

Results: Among 116 enrolled patients, 20 with prolonged or relapsed viral shedding were screened to identify the variants. Of these 20 patients, 7 (35%) exhibited evidence of re-infection; one of 8 patients with prolonged viral shedding and 6 of 12 with relapsed viral shedding were reinfected with SARS-CoV-2.

Conclusion: Our data suggest that approximately one-third of immunocompromised patients with persistent or relapsed viral shedding had reinfection with different variants of SARS-CoV-2.

{"title":"Reinfection of SARS-CoV-2 Variants in Immunocompromised Patients with Prolonged or Relapsed Viral Shedding.","authors":"Ji Yeun Kim, Euijin Chang, Hyeon Mu Jang, Jun Ho Cha, Ju Yeon Son, Choi Young Jang, Jeong-Sun Yang, Joo-Yeon Lee, Sung-Han Kim","doi":"10.3947/ic.2024.0098","DOIUrl":"https://doi.org/10.3947/ic.2024.0098","url":null,"abstract":"<p><strong>Background: </strong>Immunocompromised patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection often have prolonged viral shedding, and some are clinically suspected of reinfection with different SARS-CoV-2 variants. However, data on this issue are limited. This study investigated the SARS-CoV-2 variants in serially collected respiratory samples from immunocompromised patients with prolonged viral shedding for over 12 weeks or relapsed viral shedding after at least 2 weeks of viral clearance.</p><p><strong>Materials and methods: </strong>From February 2022 to September 2023, we prospectively enrolled immunocompromised patients with coronavirus disease 2019 who had hematologic malignancies or had undergone transplantation and were admitted to a tertiary hospital. Weekly saliva or nasopharyngeal swabs were collected from enrolled patients for at least 12 weeks after diagnosis. Genomic RNA polymerase chain reaction (PCR) was performed on samples, and those testing positive underwent viral culture to isolate the live virus. Spike gene full sequencing via Sanger sequencing and real-time reverse transcription-PCR for detecting mutation genes were conducted to identify SARS-CoV-2 variants.</p><p><strong>Results: </strong>Among 116 enrolled patients, 20 with prolonged or relapsed viral shedding were screened to identify the variants. Of these 20 patients, 7 (35%) exhibited evidence of re-infection; one of 8 patients with prolonged viral shedding and 6 of 12 with relapsed viral shedding were reinfected with SARS-CoV-2.</p><p><strong>Conclusion: </strong>Our data suggest that approximately one-third of immunocompromised patients with persistent or relapsed viral shedding had reinfection with different variants of SARS-CoV-2.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143366714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a Prediction Model for the Risk of Infection in Patients with Aplastic Anemia: Survival Analysis in Recurrent Events. 再生障碍性贫血患者感染风险预测模型的开发:复发事件的生存分析
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2024-12-01 Epub Date: 2024-08-30 DOI: 10.3947/ic.2024.0045
Pirun Saelue, Thitichaya Penthinapong

Background: In patients with aplastic anemia (AA), infection-related complications are the leading cause of mortality. However, limited knowledge about the predictive factors for infection in these patients exists. Thus, this study aimed to evaluate risk factors for infection and develop a risk prediction model for the occurrence of infection in patients with AA.

Materials and methods: Between January 2004 and December 2020, 206 patients with AA ≥15 years of age were included in this study. Survival analysis using recurrent event methodologies was conducted to identify predictive factors associated with infection, including the Anderson and Gill model; Prentice, Williams, and Peterson (PWP) Total Time model; PWP Gap Time model; marginal model; and frailty models. The best model was determined using backward stepwise regression, and internal validation was performed using the bootstrapping method with 500 re-samplings.

Results: With a median follow-up of 2.95 years, the incidence rate of infection among patients with AA was 32.8 events per 100 person-years. The PWP Total Time model revealed that cirrhosis comorbidity, lymphocytes ≥80%, and previous infection increased the risk of infection, while bone marrow cellularity ≥20% offered protection. The bone marrow cellularity, lymphocyte percentage, previous infection, cirrhosis, and hematocrit (BLICH) model was generated to predict the risk of infection. The internal validation showed a good calibration of this model.

Conclusion: Cirrhosis, lymphocytes ≥80%, previous infection, and bone marrow cellularity <20% are risk factors for infection in patients with AA. The BLICH model can predict the risk of infection in these patients.

背景:在再生障碍性贫血(AA)患者中,感染相关并发症是导致死亡的主要原因。然而,人们对这些患者感染的预测因素了解有限。因此,本研究旨在评估感染的风险因素,并建立一个AA患者发生感染的风险预测模型:2004年1月至2020年12月期间,206名年龄≥15岁的AA患者被纳入本研究。采用复发事件方法进行生存分析,以确定与感染相关的预测因素,包括安德森和吉尔模型、普伦蒂斯、威廉姆斯和彼得森(PWP)总时间模型、PWP间隙时间模型、边际模型和虚弱模型。使用后向逐步回归法确定最佳模型,并使用500次重复取样的Bootstrapping法进行内部验证:中位随访时间为 2.95 年,AA 患者的感染发生率为每 100 人年 32.8 例。PWP总时间模型显示,肝硬化合并症、淋巴细胞≥80%和既往感染增加了感染风险,而骨髓细胞率≥20%则提供了保护。骨髓细胞率、淋巴细胞百分比、既往感染、肝硬化和血细胞比容(BLICH)模型用于预测感染风险。内部验证显示该模型校准良好:肝硬化、淋巴细胞≥80%、既往感染和骨髓细胞率
{"title":"Development of a Prediction Model for the Risk of Infection in Patients with Aplastic Anemia: Survival Analysis in Recurrent Events.","authors":"Pirun Saelue, Thitichaya Penthinapong","doi":"10.3947/ic.2024.0045","DOIUrl":"10.3947/ic.2024.0045","url":null,"abstract":"<p><strong>Background: </strong>In patients with aplastic anemia (AA), infection-related complications are the leading cause of mortality. However, limited knowledge about the predictive factors for infection in these patients exists. Thus, this study aimed to evaluate risk factors for infection and develop a risk prediction model for the occurrence of infection in patients with AA.</p><p><strong>Materials and methods: </strong>Between January 2004 and December 2020, 206 patients with AA ≥15 years of age were included in this study. Survival analysis using recurrent event methodologies was conducted to identify predictive factors associated with infection, including the Anderson and Gill model; Prentice, Williams, and Peterson (PWP) Total Time model; PWP Gap Time model; marginal model; and frailty models. The best model was determined using backward stepwise regression, and internal validation was performed using the bootstrapping method with 500 re-samplings.</p><p><strong>Results: </strong>With a median follow-up of 2.95 years, the incidence rate of infection among patients with AA was 32.8 events per 100 person-years. The PWP Total Time model revealed that cirrhosis comorbidity, lymphocytes ≥80%, and previous infection increased the risk of infection, while bone marrow cellularity ≥20% offered protection. The bone marrow cellularity, lymphocyte percentage, previous infection, cirrhosis, and hematocrit (BLICH) model was generated to predict the risk of infection. The internal validation showed a good calibration of this model.</p><p><strong>Conclusion: </strong>Cirrhosis, lymphocytes ≥80%, previous infection, and bone marrow cellularity <20% are risk factors for infection in patients with AA. The BLICH model can predict the risk of infection in these patients.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"483-491"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review of Human Papillomavirus Vaccination and Associated Ethical Concerns. 人类乳头瘤病毒疫苗接种及相关伦理问题综述。
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2024-12-01 Epub Date: 2024-08-08 DOI: 10.3947/ic.2024.0070
Eric Fu, Ozdemir Erdemir, Khalil Pathan, Meaghan Brophy, Aidan Pettit

Since its Fast-Track approval by the Federal Drug Administration, the human papillomavirus (HPV) vaccine has been marked by controversies. Unconfirmed reports of adverse events in both Japan and Denmark led to suspensions of national vaccination programs, which setback the fight against cervical cancer and associated mortality and morbidity. Despite follow-up studies of vaccine adverse reports, additional randomized control trials, and review reports from both the World Health Organization and the European Commission, there is still a great deal of hesitancy around the vaccine. While all three version of the HPV vaccine have been shown to be efficacious and safe, additional ethical dilemmas deserve to be considered as well.

自联邦药品管理局快速批准人类乳头瘤病毒 (HPV) 疫苗以来,该疫苗一直饱受争议。在日本和丹麦,未经证实的不良事件报告导致国家疫苗接种计划暂停,从而阻碍了宫颈癌及其相关死亡率和发病率的防治工作。尽管对疫苗不良反应报告进行了跟踪研究,进行了更多的随机对照试验,世界卫生组织和欧盟委员会也都出具了审查报告,但人们对疫苗仍有很大的疑虑。虽然所有三种版本的 HPV 疫苗都被证明是有效和安全的,但更多的伦理难题也值得考虑。
{"title":"A Review of Human Papillomavirus Vaccination and Associated Ethical Concerns.","authors":"Eric Fu, Ozdemir Erdemir, Khalil Pathan, Meaghan Brophy, Aidan Pettit","doi":"10.3947/ic.2024.0070","DOIUrl":"10.3947/ic.2024.0070","url":null,"abstract":"<p><p>Since its Fast-Track approval by the Federal Drug Administration, the human papillomavirus (HPV) vaccine has been marked by controversies. Unconfirmed reports of adverse events in both Japan and Denmark led to suspensions of national vaccination programs, which setback the fight against cervical cancer and associated mortality and morbidity. Despite follow-up studies of vaccine adverse reports, additional randomized control trials, and review reports from both the World Health Organization and the European Commission, there is still a great deal of hesitancy around the vaccine. While all three version of the HPV vaccine have been shown to be efficacious and safe, additional ethical dilemmas deserve to be considered as well.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"432-439"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Antimicrobial Resistance Trends among Lower Respiratory Tract Pathogens in Crete, Greece, 2017-2022. 2017-2022年希腊克里特岛下呼吸道病原菌患病率及耐药趋势
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2024-12-01 DOI: 10.3947/ic.2024.0060
Sofia Maraki, Viktoria Eirini Mavromanolaki, Anna Kasimati, Evangelia Iliaki-Giannakoudaki, Dimitra Stafylaki
<p><strong>Background: </strong>Lower respiratory tract infections (LRTIs) are the most common infections in humans accounting for significant morbidity and mortality. Management of LRTIs is complicated due to increasing antimicrobial resistance. This study investigated the prevalence and trends of antimicrobial resistance for bacteria isolated from respiratory samples of patients with LRTIs.</p><p><strong>Materials and methods: </strong>Sputum and bronchial washings were collected from patients of all ages hospitalized with LRTIs and were analyzed by the microbiological laboratory in the University Hospital of Heraklion, Crete, Greece, from January 2017 to December 2022. Identification of the bacterial isolates was performed by matrix-assisted laser desorption ionization-time of flight mass spectrometry and antimicrobial susceptibility testing by Vitek 2 system.</p><p><strong>Results: </strong>A total of 4,008 strains were isolated from 3,427 respiratory samples. <i>Acinetobacter baumannii</i> was the most frequently isolated pathogen (23.1%), followed by <i>Pseudomonas aeruginosa</i> (20.0%), <i>Staphylococcus aureus</i> (10.6%) and <i>Klebsiella pneumoniae</i> (6.8%). The isolation rate of <i>A. baumannii</i> significantly increased during the study period, while there were lower increases in the isolation rates of <i>P. aeruginosa</i>, <i>K. pneumoniae</i> and <i>S. aureus. A. baumannii</i> and <i>P. aeruginosa</i> were more prevalent during summer, <i>K. pneumoniae</i> was more common during autumn, while for <i>S. aureus</i> higher incidence was noted during winter. <i>A. baumannii</i> exhibited high resistance rates (≥90.0%) to most of the antimicrobial agents tested, and extremely high multidrug-resistance (91.0%). <i>P. aeruginosa</i> showed the lowest rate of resistance for colistin (1.4%). Among β-lactams, resistance rates to piperacillin/tazobactam, ceftazidime, cefepime, imipenem and meropenem were 26.2%, 27%, 25.8%, 29.2% and 29.9%, respectively. A total of 162 (68.1%) meropenem-resistant <i>P. aeruginosa</i> were simultaneously resistant to ceftazidime and piperacillin/tazobactam. Regarding <i>K. pneumoniae</i>, high rates of resistance were observed for the third and fourth generation cephalosporins, namely cefotaxime, ceftriaxone, ceftazidime, and cefepime and the carbapenems, imipenem and meropenem ranging from 46.2% to 53.8%. Carbapenem-resistance was detected among 46.2% of the isolates. Among the 126 carbapenem-resistant <i>K. pneumoniae</i> isolates, 83 (65.9%), 30 (23.8%), 9 (7.2%), and 4 (4.2%) were positive for <i>Klebsiella pneumoniae</i> carbapenemase, New Delhi Metallo-β-lactamase, Verona Integron-Mediated Metallo-β-lactamase and OXA-48 carbapenemase, respectively. Of the total number of <i>S. aureus</i>, 37.2% were methicillin resistant. Low rates of resistance were detected in trimethoprim/sulfamethoxazole (3.3%), gentamicin (2.8%), and rifampicin (0.9%). All isolates were susceptible to linezolid, daptomycin, tigecy
背景:下呼吸道感染(LRTIs)是人类最常见的感染,具有显著的发病率和死亡率。由于抗生素耐药性的增加,下呼吸道感染的管理是复杂的。本研究调查了从下呼吸道感染患者呼吸道样本中分离的细菌的流行情况和耐药性趋势。材料与方法:收集2017年1月至2022年12月在希腊克里特岛伊拉克利安大学医院住院的所有年龄的下呼吸道感染患者的痰液和支气管洗涤液,并由微生物实验室进行分析。采用基质辅助激光解吸电离飞行时间质谱法对分离菌株进行鉴定,并用Vitek 2系统进行药敏试验。结果:从3427份呼吸道样本中共分离出4008株。鲍曼不动杆菌是最常见的病原菌(23.1%),其次是铜绿假单胞菌(20.0%)、金黄色葡萄球菌(10.6%)和肺炎克雷伯菌(6.8%)。研究期间鲍曼假单胞菌的分离率显著上升,铜绿假单胞菌、肺炎克雷伯菌和金黄色葡萄球菌的分离率上升幅度较小。鲍曼不动杆菌和铜绿假单胞菌在夏季较为常见,肺炎克雷伯菌在秋季较为常见,而金黄色葡萄球菌在冬季发病率较高。鲍曼不动杆菌对大多数抗菌药物的耐药率均较高(≥90.0%),对多种药物的耐药率极高(91.0%)。P. aeruginosa对粘菌素的耐药率最低(1.4%)。β-内酰胺类药物对哌拉西林/他唑巴坦、头孢他啶、头孢吡肟、亚胺培南、美罗培南的耐药率分别为26.2%、27%、25.8%、29.2%和29.9%。共有162株(68.1%)耐美罗培尼铜绿假单胞菌同时对头孢他啶和哌拉西林/他唑巴坦耐药。肺炎克雷伯菌对头孢噻肟、头孢曲松、头孢他啶、头孢吡肟等第三代和第四代头孢菌素以及碳青霉烯类、亚胺培南、美罗培南的耐药率为46.2% ~ 53.8%。46.2%的菌株对碳青霉烯类药物耐药。126株耐碳青霉烯肺炎克雷伯菌碳青霉烯酶、新德里金属β-内酰胺酶、维罗纳整合子介导的金属β-内酰胺酶和OXA-48碳青霉烯酶分别阳性83株(65.9%)、30株(23.8%)、9株(7.2%)和4株(4.2%)。金黄色葡萄球菌对甲氧西林耐药的占37.2%。甲氧苄啶/磺胺甲恶唑的耐药率较低(3.3%),庆大霉素(2.8%),利福平(0.9%)。所有分离株均对利奈唑胺、达托霉素、替加环素、替可普宁和万古霉素敏感。结论:定期更新当地微生物流行监测和耐药模式监测对指导经验性下呼吸道感染的治疗至关重要。
{"title":"Prevalence and Antimicrobial Resistance Trends among Lower Respiratory Tract Pathogens in Crete, Greece, 2017-2022.","authors":"Sofia Maraki, Viktoria Eirini Mavromanolaki, Anna Kasimati, Evangelia Iliaki-Giannakoudaki, Dimitra Stafylaki","doi":"10.3947/ic.2024.0060","DOIUrl":"https://doi.org/10.3947/ic.2024.0060","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Lower respiratory tract infections (LRTIs) are the most common infections in humans accounting for significant morbidity and mortality. Management of LRTIs is complicated due to increasing antimicrobial resistance. This study investigated the prevalence and trends of antimicrobial resistance for bacteria isolated from respiratory samples of patients with LRTIs.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;Sputum and bronchial washings were collected from patients of all ages hospitalized with LRTIs and were analyzed by the microbiological laboratory in the University Hospital of Heraklion, Crete, Greece, from January 2017 to December 2022. Identification of the bacterial isolates was performed by matrix-assisted laser desorption ionization-time of flight mass spectrometry and antimicrobial susceptibility testing by Vitek 2 system.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 4,008 strains were isolated from 3,427 respiratory samples. &lt;i&gt;Acinetobacter baumannii&lt;/i&gt; was the most frequently isolated pathogen (23.1%), followed by &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt; (20.0%), &lt;i&gt;Staphylococcus aureus&lt;/i&gt; (10.6%) and &lt;i&gt;Klebsiella pneumoniae&lt;/i&gt; (6.8%). The isolation rate of &lt;i&gt;A. baumannii&lt;/i&gt; significantly increased during the study period, while there were lower increases in the isolation rates of &lt;i&gt;P. aeruginosa&lt;/i&gt;, &lt;i&gt;K. pneumoniae&lt;/i&gt; and &lt;i&gt;S. aureus. A. baumannii&lt;/i&gt; and &lt;i&gt;P. aeruginosa&lt;/i&gt; were more prevalent during summer, &lt;i&gt;K. pneumoniae&lt;/i&gt; was more common during autumn, while for &lt;i&gt;S. aureus&lt;/i&gt; higher incidence was noted during winter. &lt;i&gt;A. baumannii&lt;/i&gt; exhibited high resistance rates (≥90.0%) to most of the antimicrobial agents tested, and extremely high multidrug-resistance (91.0%). &lt;i&gt;P. aeruginosa&lt;/i&gt; showed the lowest rate of resistance for colistin (1.4%). Among β-lactams, resistance rates to piperacillin/tazobactam, ceftazidime, cefepime, imipenem and meropenem were 26.2%, 27%, 25.8%, 29.2% and 29.9%, respectively. A total of 162 (68.1%) meropenem-resistant &lt;i&gt;P. aeruginosa&lt;/i&gt; were simultaneously resistant to ceftazidime and piperacillin/tazobactam. Regarding &lt;i&gt;K. pneumoniae&lt;/i&gt;, high rates of resistance were observed for the third and fourth generation cephalosporins, namely cefotaxime, ceftriaxone, ceftazidime, and cefepime and the carbapenems, imipenem and meropenem ranging from 46.2% to 53.8%. Carbapenem-resistance was detected among 46.2% of the isolates. Among the 126 carbapenem-resistant &lt;i&gt;K. pneumoniae&lt;/i&gt; isolates, 83 (65.9%), 30 (23.8%), 9 (7.2%), and 4 (4.2%) were positive for &lt;i&gt;Klebsiella pneumoniae&lt;/i&gt; carbapenemase, New Delhi Metallo-β-lactamase, Verona Integron-Mediated Metallo-β-lactamase and OXA-48 carbapenemase, respectively. Of the total number of &lt;i&gt;S. aureus&lt;/i&gt;, 37.2% were methicillin resistant. Low rates of resistance were detected in trimethoprim/sulfamethoxazole (3.3%), gentamicin (2.8%), and rifampicin (0.9%). All isolates were susceptible to linezolid, daptomycin, tigecy","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"56 4","pages":"492-501"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Can Chronic COVID (Long-COVID Syndrome) Be Diagnosed and Treated? 如何诊断和治疗慢性COVID(长冠综合征)?
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2024-12-01 DOI: 10.3947/ic.2024.0115
Josef Finsterer
{"title":"How Can Chronic COVID (Long-COVID Syndrome) Be Diagnosed and Treated?","authors":"Josef Finsterer","doi":"10.3947/ic.2024.0115","DOIUrl":"https://doi.org/10.3947/ic.2024.0115","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"56 4","pages":"559-560"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704858/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Antimicrobial Susceptibility of Wound Pathogens in a Tertiary Care Hospital in Kashmir: A Cross-sectional Study. 克什米尔一家三级护理医院伤口病原菌的患病率和抗菌药物敏感性:一项横断面研究。
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2024-12-01 DOI: 10.3947/ic.2024.0083
Tabeen Mansoor, Dekyong Angmo, Nahid Nehvi

Background: Wound infections significantly impact morbidity, mortality, and healthcare costs globally. The Kashmir Valley's unique geographical and climatic conditions, coupled with resource constraints and antibiotic misuse, complicate managing these infections effectively. This study aimed to identify predominant bacterial pathogens in wound infections at a tertiary care hospital in Kashmir, determine their antibiotic susceptibility profiles, and estimate the prevalence of multidrug-resistant (MDR) strains.

Materials and methods: A prospective cross-sectional study was conducted from January to June 2023 at the Government Medical College, Srinagar. Pus samples from wound infections were aseptically collected and processed following standard microbiological protocols. Antibiotic susceptibility testing utilized the Kirby-Bauer disk diffusion method, adhering to Clinical and Laboratory Standards Institute guidelines. Data were analyzed using IBM SPSS statistics.

Results: Out of 4,378 samples analyzed, bacterial growth was observed in 1,921 samples, representing 43.9% of the total. Among the bacterial isolates, Gram-negative bacilli accounted for 73.5%, with Escherichia coli being the most prevalent at 27.9%. Among Gram-positive cocci, Staphylococcus aureus predominated, comprising 25.9% of the isolates. Methicillin-resistant S. aureus exhibited 100% susceptibility to linezolid but low susceptibility to erythromycin (27.0%) and clindamycin (24.0%). E. coli demonstrated high susceptibility to tigecycline (97.4%) and amikacin (75.0%), but lower susceptibility to imipenem (45.0%) and piperacillin-tazobactam (57.8%).

Conclusion: The substantial wound infection burden and high MDR prevalence in Kashmir necessitate comprehensive antimicrobial stewardship and infection control programs. Regular surveillance, education, and research are crucial to address antibiotic resistance and ensure effective wound infection management in the region.

背景:伤口感染显著影响全球发病率、死亡率和医疗保健成本。克什米尔山谷独特的地理和气候条件,加上资源限制和抗生素滥用,使有效管理这些感染复杂化。本研究旨在确定克什米尔一家三级护理医院伤口感染的主要细菌病原体,确定其抗生素敏感性概况,并估计多重耐药(MDR)菌株的患病率。材料和方法:一项前瞻性横断面研究于2023年1月至6月在斯利那加政府医学院进行。无菌收集伤口感染脓液样本,并按照标准微生物学方案进行处理。抗生素敏感性测试采用Kirby-Bauer圆盘扩散法,遵循临床和实验室标准协会的指导方针。数据采用IBM SPSS统计软件进行分析。结果:在分析的4378个样本中,1921个样本中观察到细菌生长,占总数的43.9%。其中革兰氏阴性杆菌占73.5%,大肠杆菌最多,占27.9%。在革兰氏阳性球菌中,金黄色葡萄球菌占多数,占25.9%。耐甲氧西林金黄色葡萄球菌对利奈唑胺的敏感性为100%,对红霉素(27.0%)和克林霉素(24.0%)的敏感性低。大肠杆菌对替加环素(97.4%)和阿米卡星(75.0%)的敏感性较高,对亚胺培南(45.0%)和哌拉西林-他唑巴坦(57.8%)的敏感性较低。结论:克什米尔地区伤口感染负担沉重,耐多药耐药患病率高,需要全面的抗菌药物管理和感染控制规划。定期监测、教育和研究对于解决该地区的抗生素耐药性和确保有效的伤口感染管理至关重要。
{"title":"Prevalence and Antimicrobial Susceptibility of Wound Pathogens in a Tertiary Care Hospital in Kashmir: A Cross-sectional Study.","authors":"Tabeen Mansoor, Dekyong Angmo, Nahid Nehvi","doi":"10.3947/ic.2024.0083","DOIUrl":"https://doi.org/10.3947/ic.2024.0083","url":null,"abstract":"<p><strong>Background: </strong>Wound infections significantly impact morbidity, mortality, and healthcare costs globally. The Kashmir Valley's unique geographical and climatic conditions, coupled with resource constraints and antibiotic misuse, complicate managing these infections effectively. This study aimed to identify predominant bacterial pathogens in wound infections at a tertiary care hospital in Kashmir, determine their antibiotic susceptibility profiles, and estimate the prevalence of multidrug-resistant (MDR) strains.</p><p><strong>Materials and methods: </strong>A prospective cross-sectional study was conducted from January to June 2023 at the Government Medical College, Srinagar. Pus samples from wound infections were aseptically collected and processed following standard microbiological protocols. Antibiotic susceptibility testing utilized the Kirby-Bauer disk diffusion method, adhering to Clinical and Laboratory Standards Institute guidelines. Data were analyzed using IBM SPSS statistics.</p><p><strong>Results: </strong>Out of 4,378 samples analyzed, bacterial growth was observed in 1,921 samples, representing 43.9% of the total. Among the bacterial isolates, Gram-negative bacilli accounted for 73.5%, with <i>Escherichia coli</i> being the most prevalent at 27.9%. Among Gram-positive cocci, <i>Staphylococcus aureus</i> predominated, comprising 25.9% of the isolates. Methicillin-resistant <i>S. aureus</i> exhibited 100% susceptibility to linezolid but low susceptibility to erythromycin (27.0%) and clindamycin (24.0%). <i>E. coli</i> demonstrated high susceptibility to tigecycline (97.4%) and amikacin (75.0%), but lower susceptibility to imipenem (45.0%) and piperacillin-tazobactam (57.8%).</p><p><strong>Conclusion: </strong>The substantial wound infection burden and high MDR prevalence in Kashmir necessitate comprehensive antimicrobial stewardship and infection control programs. Regular surveillance, education, and research are crucial to address antibiotic resistance and ensure effective wound infection management in the region.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"56 4","pages":"502-509"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Infection and Chemotherapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1